10.02.15
The first patient surgical implantation of the Alphatec Neocore osteoconductive matrix, a synthetic scaffold for the regeneration of bone, was successfully completed. The device is product of Alphatec Spine Inc., a subsidiary of Carlsbad, Calif.-based Alphatec Holdings Inc.
“Alphatec Neocore provides surgeons with the handling characteristics and osteoconductive composition they’ve been looking for in bone grafting products,” said Jim Corbett, president and CEO of Alphatec Spine. “Alphatec Neocore will expand our biologics opportunity—both here in the United States and internationally. This exciting new global biologic brand will give us the ability to operate more broadly in the global marketplace, bringing a compelling synthetic bone regeneration solution and competitive pricing to our surgeon and hospital customers worldwide.”
Alphatec Neocore osteoconductive matrix is a synthetic scaffold that is designed to provide an effective core environment for bone growth. When hydrated with patient bone marrow aspirate (BMA), Alphatec Neocore becomes a complete bone graft, which possesses all the necessary components of bone growth. Engineered to perform like natural bone, Alphatec Neocore’s composition and porosity provide the benefits of rapid revascularization throughout graft and supports replacement of three-dimensional matrix with healthy new bone growth, the company claims.
“Alphatec Neocore provides surgeons with the handling characteristics and osteoconductive composition they’ve been looking for in bone grafting products,” said Jim Corbett, president and CEO of Alphatec Spine. “Alphatec Neocore will expand our biologics opportunity—both here in the United States and internationally. This exciting new global biologic brand will give us the ability to operate more broadly in the global marketplace, bringing a compelling synthetic bone regeneration solution and competitive pricing to our surgeon and hospital customers worldwide.”
Alphatec Neocore osteoconductive matrix is a synthetic scaffold that is designed to provide an effective core environment for bone growth. When hydrated with patient bone marrow aspirate (BMA), Alphatec Neocore becomes a complete bone graft, which possesses all the necessary components of bone growth. Engineered to perform like natural bone, Alphatec Neocore’s composition and porosity provide the benefits of rapid revascularization throughout graft and supports replacement of three-dimensional matrix with healthy new bone growth, the company claims.